PTX-101

N/A

Report date: 2026/05/13 11:18:06

Base Information

Drug NamePTX-101

Drug Alias NamePTX-101

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccinesVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProvidence Therapeutics Holdings Inc

China Registration ClassN/A

Develop Information

Active CompaniesProvidence Therapeutics Holdings Inc

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A